(Q41602314)

4 October 2017

title

Valproate-induced hepatic injury: analyses of 23 fatal cases (English)

1 reference

4 October 2017

Zimmerman HJ

1

1 reference

4 October 2017

Ishak KG

series ordinal

2

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 September 1982

1 reference

4 October 2017

1 reference

4 October 2017

volume

2

1 reference

4 October 2017

issue

5

1 reference

4 October 2017

page(s)

591-597

1 reference

Drug therapy: Valproic acid

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Hepatic Failure from Valproic Acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Reye-like syndrome associated with valproic acid therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Acute Hepatic Failure Associated with the Use of Sodium Valproate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Fatal Reye-like syndrome associated with valproic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Fatal hepatic failure and sodium valproate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Sodium valproate and ornithine carbamyl transferase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Jamaican vomiting sickness. Biochemical investigation of two cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Production of the Features of Reye's Syndrome in Rats with 4-Pentenoic Acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Concentration of metabolites of valproic acid in plasma of epileptic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Dipropylacetate (valproate) and glycine metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Valproic acid and secondary hyperammonemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Effect of valproic acid on hepatic function

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

A Direct Hepatotoxic Effect of Valproic Acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Valproic acid therapy in childhood epilepsy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Phenobarbital--valporic acid interaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Hepatic Oncocytes: Incidence, Staining Characteristics, and Ultrastructural Features

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Oxyphilic granular hepatocytes. Mitochondrion-rich liver cells in hepatic disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840020513

7 January 2021

Identifiers

DOI

10.1002/HEP.1840020513

0 references

1 reference